Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
168
days
Parametric delineation of the clinical target volume for glioma: Model-based approach that tailors to physician contouring practices
AuthorsGregory Buti; Ali Ajdari; Christopher Bridge; Ariel E. Marciscano; Gregory C. Sharp; Kevin Oh; Fredrik Löfman; Helen A. Shih; Thomas Bortfeld
AffiliationsMassachusetts General Hospital/Mass General Brigham and Harvard Medical School, Department of Radiation Oncology, 100 Blossom St, Boston, MA 02114, USA; Massachusetts General Hospital/Mass General Brigham and Harvard Medical School, Athinoula A. Martinos Center for Biomedical Imaging, 149 Thirteenth St, Charlestown, MA 02129, USA; RaySearch Laboratories AB, Eugeniavägen 18C, SE-104 30 Stockholm, Sweden; Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Ave, Boston, MA 02215, USA
41
days
When progression-free survival fails to inform: the need for event-level reporting in oligometastatic radiotherapy trials
AuthorsCole Friedes; David Palma; Nina N. Sanford
AffiliationsDepartment of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Department of Radiation Oncology, London Health Sciences Centre, London, Ontario, Canada; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA
59
days
A versatile phantom-based framework for end-to-end testing of (online) adaptive proton therapy in the head-and-neck region
AuthorsJacob Brunner; Francesca Albertini; Giuliano Perotti Bernardini; Stefanie Bertschi; Stefan Both; Evangelia Choulilitsa; Dietmar Georg; Stine Korreman; Gabriel Guterres Marmitt; Kenneth Poels; Christian Richter; Edmond Sterpin; Markus Stock; Kristin Stützer; Nadine Vatterodt; Barbara Knäusl
AffiliationsDepartment of Radiation Oncology, Medial University of Vienna, Vienna, Austria; MedAustron Ion Therapy Centre, Wiener Neustadt, Austria; Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands; OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; Department of Physics, ETH Zürich, Zürich, Switzerland; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Radiotherapy and Radiation Oncology, University Hospitals Leuven, Louvain, Belgium; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology – OncoRay, Dresden, Germany; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; KU Leuven, Department of Oncology, Experimental Radiotherapy Lab, Leuven, Belgium; UCLouvain, Institut de Recherce Expérimentale et Clinique, MIRO Lab, Brussels, Belgium; Department of Medical Physics at the MedAustron site in Wiener Neustadt, Faculty of Medicine, Karl Landsteiner University, Marie Curie-Straße 5, 2700 Wiener Neustadt, Austria; Christian Doppler Laboratory for Image and Knowledge Driven Precision Radiation Oncology, Medical University of Vienna, Vienna, Austria
116
days
Combined ultra-high and conventional dose rate irradiation spares murine normal skin and intestine from radiation induced acute toxicity
AuthorsA. Sesink; L. Soutter; T.T. Böhlen; R. Geyer; R. Moeckli; C. Bailat; V. Grilj
AffiliationsDepartment of Radiation Oncology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland; Imaging, Innovative Radiotherapy and System Medicine, UMR9029 CNRS, U1353 Inserm, Versailles Saint-Quentin University, PSL Research University, Institut Curie, Orsay, Saint-Cloud, Paris, France; Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland
162
days
Induction TPF versus adjuvant PF after CCRT in locally advanced nasopharyngeal carcinoma: A multicenter, randomized controlled phase III clinical trial
AuthorsQianyong He; Yuanyuan Li; Jinhua Long; Xiuling Luo; Xiuyun Gong; Weili Wu; Xiaoxiao Chen; Faqiang Ma; Xiaoxia Gou; Li Luo; Lina Liu; Zhuoling Li; Chaofen Zhao; Huajing Wu; Feng Jin
AffiliationsDepartment of Oncology, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China; Department of Oncology, the Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, Guizhou, China; Department of Oncology, the Second Affiliated Hospital of Guizhou Medical University, Kaili, Guizhou, China; Department of Oncology, the Second Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China; Department of Oncology, Guihang Guiyang Hospital, Guiyang, Guizhou, China
90
days
Radon inhalation reduces LPS-induced pneumonia symptoms in mice and promotes immunosuppression in the lung
AuthorsLydia Meziani; Sylvie Lerchl; Lisa Bouarroudj; Charlotte Robert; Olga Sokol; Daniela Kraft; Julius Oppermann; Eric Deutsch; Claudia Fournier
AffiliationsINSERM U1355, Molecular Radiotherapy and Therapeutic Innovation, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France; Biophysics Department, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France
91
days
External validation of a head & neck cancer outcome prediction model in radiotherapy patients: Evaluating generalisability in a geographically diverse population, with particular consideration of older patients
AuthorsFarhannah Aly; Joseph Descallar; Kristy Robledo; Purnima Sundaresan; Alexis Andrew Miller; Shalini Vinod; Lois Holloway
AffiliationsSouthwest Sydney Clinical Campus, University of New South Wales, Sydney, Australia; Liverpool and Macarthur Cancer Therapy Centres, SWSLHD, Liverpool, Sydney, Australia; Ingham Institute for Applied Medical Research, Liverpool, Sydney, Australia; NHMRC Clinical Trial Centre, University of Sydney, Sydney, Australia; Sydney West Radiation Oncology Network, WSLHD, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Illawarra Cancer Care Centre, ISLHD, Wollongong, Australia; Institute of Medical Physics, School of Physics, University of Sydney, Sydney, Australia
107
days
Single-cell and spatial transcriptomics delineate the remodeling of esophageal squamous-cell carcinoma ecosystem following diverse therapies
AuthorsZhe Li; Yongheng Yang; Xiaoyang Yin; Chunyan Zheng; Mengya Zhang; Lei Feng; Chengxin Liu; Xiaolu Zhang; Baosheng Li
AffiliationsDepartment of Pulmonary and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China; Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China; Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China; Department of Radiation Oncology, Tumor Research and Therapy Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China; State Key Laboratory of Advanced Drug Delivery and Release Systems, Shandong, China
137
days
Inequitable access to proton beam therapy in Europe: Efficiency, equity, and strategic infrastructure planning to 2030
AuthorsDominik Wawrzuta; Justyna Klejdysz; Katarzyna Pędziwiatr; Marzanna Chojnacka
AffiliationsDepartment of Radiation Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Wawelska 15B, 02-034 Warsaw, Poland; Department of Economics, Ludwig Maximilian University of Munich (LMU), Geschwister-Scholl-Platz 1, 80539 Munich, Germany; ifo Institute, Poschinger Straße 5, 81679 Munich, Germany
164
days
Early regression index-guided adaptive dose escalation in locally advanced rectal cancer: results of the prospective THUNDER-2 trial
AuthorsG. Chiloiro; A. Romano; L. Boldrini; F. de Giacomo; G. Panza; F. Bono; HE Tran; M. Nardini; L. Placidi; D. Cusumano; R. Menghi; F. Barbaro; S. Pecere; M.A. Gambacorta
AffiliationsDepartment of Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Mater Olbia Hospital, Strada Statale Orientale Sarda 125, Olbia 07026, Italy
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days